Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY 4.0HemaSphere

The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism

Related

  1. Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study.
    Hyung-Jun Lim, Kunye Kwak, Changgon Kim +5
    Research and practice in thrombosis and haemostasisPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Mechanism of growth arrest-specific protein 6/Axl receptor tyrosine kinase signaling pathway in promoting macrophage polarization and contributing to interstitial fibrosis in IgA nephropathy
    Yang Shu-fen, Zhu Guo-qiang, Meng Zhao-xi +4
    Linchuang shenzangbing zazhiPeer-reviewedCC BY-NC-NDFull textGeneral medicineDOAJ
  3. Molecular Mechanisms and Therapeutic Advances in KRAS G12C‐Mutant Non‐Small Cell Lung Cancer: Toward Mechanism‐Guided Longitudinal Management
    Haiying Wang, Hanxiao Chen, Sheng Li +1
    Cancer innovationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies
    Yunda Hong, Dabing Chen, Jingjing Xu +14
    ISciencePeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCCrossref
  5. Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
    Chetan C Oturkar, Junhoung Park J, Iqbal Ijaz +21
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
BibTeX
@article{lees2026thrombopoietin,
  title = {{The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism}},
  author = {Charlotte Lees and Emile Brandt and Emmanuel Dutranoix and Gabriel Levy and Bogdan I. Iorga and Hosuk Ryou and Jens Rittscher and Daniel Royston and Stefan Constantinescu and Adam Mead},
  journal = {HemaSphere},
  year = {2026},
  month = oct,
  doi = {10.1002/hem3.70437},
  url = {https://hal.science/hal-05790492v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism
AU  - Charlotte Lees
AU  - Emile Brandt
AU  - Emmanuel Dutranoix
AU  - Gabriel Levy
AU  - Bogdan I. Iorga
AU  - Hosuk Ryou
AU  - Jens Rittscher
AU  - Daniel Royston
AU  - Stefan Constantinescu
AU  - Adam Mead
PY  - 2026
DA  - 2026/10/07
JO  - HemaSphere
DO  - 10.1002/hem3.70437
UR  - https://hal.science/hal-05790492v1
SN  - 2572-9241
ER  -